Hongliang Zhang

Dr. Hongliang Zhang


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2024 in Journal of Inflammation Research
Verified
Journal Article
Open access
PDF file
SGShuai Guo
Shuai Guo
ZGZhaoting Gong
Zhaoting Gong
XSXiaona Sun
Xiaona Sun
FGFei Gao
Fei Gao
XLXiang Li
Xiang Li
HGHai Gao
Hai Gao
Background: Ischemic cardiomyopathy (ICM) significantly contributes to global disease burden, while the role of ferroptosis in ICM remains underexplored. Methods: We identified differentially expressed ferroptosis-related genes (DEFRGs) by analyzing the GSE57338 dataset and cross-referencing with FerrDb. Consensus clustering was then used to identify ferroptosis-associated clusters within the ICM samples. A ferroptosis-specific predictive signature was developed using the least absolute shrinkage and selection operator (LASSO) method and validated with the GSE5406 dataset. Additionally, quantitative real-time PCR (qRT-PCR) experiments were performed to validate the 11 feature genes in a rat ICM model. Results: We identified 15 DEFRGs in GSE57338, which distinguished two patient clusters with distinct ferroptosis gene expression, pathway enrichment profiles, and metabolic characteristics. All DEFRGs were upregulated in cluster 2. Potential therapeutic targets were also identified for different ICM patient clusters. The 11-gene predictive signature (TXNRD1, STEAP3, STAT3, SCL2A1, PLIN2, NQO1, NNMT, IL33, ENPP2, ARRDC3, ALOX5) showed robust predictive power in both training and validation sets. High-risk patients exhibited increased infiltration of CD8+ T cells, CD4+ naïve T cells, M0/M1 macrophages, and resting mast cells, along with significant enrichment in epithelial mesenchymal transition and interferon responses. Low-risk patients had higher infiltration of regulatory T cells and monocytes. Results of qPCR analysis confirmed the bioinformatic analysis, validating the expression of the 11 feature genes in the rat ICM model. Conclusion: We identified two ferroptosis-related clusters in ICM patients and developed a predictive signature based on ferroptosis-related genes. Our findings highlight the importance of ferroptosis in ICM and offer new insights for its diagnosis and treatment.

1 September 2020 in World Allergy Organization Journal
Verified
Journal Article
Open access
ZHZhiwei Huang
Zhiwei Huang
HZHongliang Zhang
Hongliang Zhang
YWYong Wang
Yong Wang
WYWeixian Yang
Weixian Yang
SQShubin Qiao
Shubin Qiao
FHFenghuan Hu
Fenghuan Hu
This study aimed to investigate the clinical characteristics and impact of intra-aortic balloon pump (IABP) implantation on the prognosis of patients with anaphylactic shock (AS) during cardiac catheterization. We analyzed the medical records of 34 patients who had AS caused by iodine contrast media (ICM) between January 2009 and December 2019. Clinical features and treatments were analyzed, and patients were categorized into survival and dead groups. In addition, the patients were further divided into IABP and non-IABP (NIABP) groups to assess the impact on AS according to whether a IABP was used or not. Of the 417,938 patients in whom ICM was used, 34 with AS were monitored. The prevalence of AS was 0.008%. Among the 34 patients, 6 (0.001%) died from fatal anaphylactic reactions accompanying shock, 26 (76.5%) had hypotension as the first presentation of AS in the survival and dead groups (78.6% and 66.7%, respectively), and 5 (14.7%) had unconsciousness at the initial onset of AS. The subgroup analysis revealed a higher mortality in the IABP group than in the NIABP (4/9, 44.4% vs. 2/25, 8%; P = 0.031). The present study suggests a low prevalence of ICM-related AS. Hypotension was more frequent in AS related to ICM, and unconsciousness at the initial onset of AS implied a poor prognosis. The use of an IABP did not improve the outcome of the patients with AS. IABP implantation should not be used as a routine treatment for patients with AS.

28 May 2025 in International Journal of Surgery
Verified
Journal Article
Open access
BZBin Zhang
Bin Zhang
ZLZiang Li
Ziang Li
YYYunqing Ye
Yunqing Ye
ZLZhe Li
Zhe Li
ZZZhenyan Zhao
Zhenyan Zhao
HZHongliang Zhang
Hongliang Zhang
Background: The C-reactive to albumin ratio (CAR) integrates the pro-inflammatory and nutritional status of patients, which may provide superior prognostic information over either parameter alone in valvular heart disease (VHD). The study aims to examine the association between CAR and mortality and its ability as biomarker to guide risk stratification in VHD patients. Materials and methods: A total of 5519 patients (age ≥18 years) with moderate or severe VHD from a multicenter prospective cohort underwent echocardiography and CAR measurement. VHD examined included aortic stenosis, aortic regurgitation, mitral stenosis, mitral regurgitation; tricuspid regurgitation, and multi VHD. An optimal threshold of 0.15 was defined based on penalized splines and receiver operating characteristic curves. The primary outcome was all-cause mortality. Results: The cohort had a mean age of 61.9 ± 13.7 years, and 2997 (54.3%) were men. At 2-year follow-up, 482 (8.7%) deaths occurred. Penalized splines showed a monotonic increase of relative hazards with greater CAR for death. Higher CAR was independently associated with mortality (overall adjusted hazard ratio [aHR]: 1.89; 95% confidence interval [CI]: 1.56–2.28; P < 0.001) and major adverse cardiovascular events (aHR: 1.40; 95% CI: 1.30–1.82; P < 0.001). Different subtypes of VHD incurred excess mortality with elevated CAR. Results remained consistent in patients under medical care. The CAR threshold combined with NT-proBNP amplified the stratification of patients at risk (log-rank, P < 0.001). The addition of CAR to a prediction algorithm including traditional risk factors improved outcome prediction (continuous net reclassification index [NRI]: 0.57; likelihood ratio test P < 0.001) and reclassified better in patients both with and without events (absolute NRI: 4.3%). Conclusions: CAR provides incremental prognostic information for mortality in various VHD. It could aid in risk stratification as a dependable and accessible tracking tool of prognosis in VHDs.

1 February 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
yang chenyang chen
yang chen
MFMisbahul Ferdous
Misbahul Ferdous
LKLAKSHME KOTTU
LAKSHME KOTTU
JZJie Zhao
Jie Zhao
HZHongliang Zhang
Hongliang Zhang
YWYong-Jian Wu
Yong-Jian Wu
Introduction: Chronic severe aortic regurgitation (AR) has a poor long-term prognosis, especially among old-age patients. Considering their advancing age, the surgical approach of aortic valve replacement may not always be the best alternative modality of treatment in such patients. Therefore, this study’s primary goal was to provide an initial summary of the medium- and short-term clinical effectiveness of transcatheter aortic valve replacement (TAVR) guided by accurate multi-detector computed tomography (MDCT) measurements in patients with severe and chronic AR, especially in elderly patients. Methods: The study enrolled retrospectively and prospectively patients diagnosed with severe AR who eventually underwent TAVR procedure from January 2019 to September 2022 at Fuwai cardiovascular Hospital, Beijing. Baseline information, MDCT measurements, anatomical classification, perioperative, and 1-year follow-up outcomes were collected and analyzed. Based on a novel anatomical categorization and dual anchoring theory, patients were divided into four categories according to the level of anchoring area. Type 1, 2, and 3 patients (with at least two anchoring regions) will receive TAVR with a transcatheter heart valve (THV), but Type 4 patients (with zero or one anchoring location) will be deemed unsuitable for TAVR and will instead receive medical care (retrospectively enrolled patients who already underwent TAVR are an exception). Results: The mean age of the 37 patients with severe chronic AR was 73.1 ± 8.7 years, and 23 patients (62.2%) were male. The American Association of Thoracic Surgeons’ score was 8.6 ± 2.1%. The MDCT anatomical classification included 17 cases of type 1 (45.9%), 3 cases of type 2 (8.1%), 13 cases of type 3 (35.1%), and 4 cases of Type 4 (10.8%). The VitaFlow valve (MicroPort, Shanghai, China) was implanted in 19 patients (51.3%), while the Venus A valve (Venus MedTech, Hangzhou, China) was implanted in 18 patients (48.6%). Immediate TAVR procedural and device success rates were 86.5% and 67.6%, respectively, while eight cases (21.6%) required THV-in-THV implantation, and nine cases (24.3%) required permanent pacemaker implantation. Univariate regression analysis revealed that the major factors affecting TAVR device failure were sinotubular junction diameter, THV type, and MDCT anatomical classification (p < 0.05). Compared with the baseline, the left ventricular ejection fraction gradually increased, while the left ventricular end-diastolic diameter remained small, and the N-terminal-pro hormone B-type natriuretic peptide level significantly decreased within one year. Conclusion: According to the results of our study, TAVR with a self-expanding THV is safe and feasible for patients with chronic severe AR, particularly for those who meet the criteria for the appropriate MDCT anatomical classification with intact dual aortic anchors, and it has a significant clinical effect for at least a year.

18 April 2025 in International Journal of Cardiology
Verified
Journal Article
Closed access
WSWence Shi
Wence Shi
MWMoyang Wang
Moyang Wang
GNGuannan Niu
Guannan Niu
ZZZhenyan Zhao
Zhenyan Zhao
ZZZheng Zhou
Zheng Zhou
HZHongliang Zhang
Hongliang Zhang

4 March 2025 in Journal of the American Heart Association
Verified
Journal Article
Open access
WSWence Shi
Wence Shi
HZHongliang Zhang
Hongliang Zhang
LSLei Song
Lei Song
TZTongqiang Zou
Tongqiang Zou
LXLihua Xie
Lihua Xie
YZYuxuan Zhang
Yuxuan Zhang
Background: The coronary microcirculatory resistance index plays a crucial role in predicting patient prognosis. Coronary angiography‐based methods for assessing coronary microcirculatory function offer advantages such as simplicity and cost‐effectiveness. This study aimed to confirm the prognostic value of a novel angiographic microvascular resistance (AMR) index in patients undergoing transcatheter aortic valve replacement. Methods and Results: We prospectively included 335 patients with severe aortic stenosis who underwent transcatheter aortic valve replacement at Fuwai Hospital. The AMR was calculated based on coronary angiography performed before prosthetic valve implantation. Patients were divided into 2 groups based on an AMR cutoff value of 250: AMR ≤250 and AMR >250. The primary end point was major adverse cardiovascular events, defined as a composite of all‐cause mortality, readmission for heart failure, and myocardial infarction. At a median follow‐up of 40 months (interquartile range [IQR], 25–50), AMR was significantly higher in patients who experienced the primary end point (257 [IQR, 186–299] versus 226 [IQR, 177–264]; P 250 had significantly lower event‐free survival rates for major adverse cardiovascular events (62.9% versus 75.1%; hazard ratio, 1.94 [95% CI, 1.34–2.81]; log‐rank P <0.001), mainly driven by all‐cause death (75.7% versus 83.4%, log‐rank P =0.018). Subgroup analyses supported these findings for major adverse cardiovascular events. Conclusions: AMR is an independent predictor of adverse clinical outcomes after transcatheter aortic valve replacement. An AMR >250 can be used as a novel indicator for long‐term prognostic management.